VERA Vera Therapeutics, Inc.

NASDAQ
$34.05

Vera Therapeutics, Inc. (VERA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with VERA's own trailing one-year pace, with 83% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 1 seller in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
8
32 transactions
Purchases
$250.0K
5,882 shares
Sales
$11.6M
290,305 shares
Net activity
-$11.4M
purchases less sales

How much of that selling was preplanned? 83% planned / 17% discretionary

10b5-1 plan sales $9.7M 23 transactions · 237,951 shares
Discretionary sales $1.9M 9 transactions · 52,354 shares

Largest single sale: $1.4M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: December 11, 2025 , by ENRIGHT PATRICK G .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Fordyce Marshall PRESIDENT AND CEO Sell 10b5-1 18,500 $35.12 $649.6K 235,244 −7.3% of holding
Fordyce Marshall 8 fills PRESIDENT AND CEO Sell 10b5-1 92,500 $42.30 $3.9M 280,494 −24.8% of holding
Fordyce Marshall 4 fills PRESIDENT AND CEO Sell 10b5-1 37,000 $37.93 $1.4M 235,332 −13.6% of holding
Fordyce Marshall 4 fills PRESIDENT AND CEO Sell 10b5-1 37,000 $36.74 $1.4M 239,525 −13.4% of holding
Fordyce Marshall 3 fills PRESIDENT AND CEO Sell 10b5-1 22,951 $44.05 $1.0M 244,065 −8.6% of holding
Fordyce Marshall PRESIDENT AND CEO Sell 16,925 $41.98 $710.6K 257,163 −6.2% of holding
Grant Sean CHIEF FINANCIAL OFFICER Sell 4,949 $41.98 $207.8K 114,181 −4.2% of holding
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR Sell 3,117 $41.98 $130.9K 64,722 −4.6% of holding
JOHNSON DAVID LEE Chief Operating Officer Sell 2,579 $41.98 $108.3K 45,727 −5.3% of holding
Turner William D. Chief Regulatory Officer Sell 2,187 $41.98 $91.8K 45,313 −4.6% of holding
Brenner Robert Chief Medical Officer Sell 2,151 $41.98 $90.3K 50,947 −4.1% of holding
Skelton Laurence Matthew Chief Commercial Officer Sell 1,582 $41.98 $66.4K 64,218 −2.4% of holding
Turner William D. Chief Regulatory Officer Sell 10b5-1 10,000 $50.08 $500.8K 22,500 −30.8% of holding
ENRIGHT PATRICK G Director Buy 5,882 $42.50 $250.0K 5,882
Turner William D. Chief Regulatory Officer Sell 10b5-1 10,000 $45.31 $453.1K 22,500 −30.8% of holding
Turner William D. Chief Regulatory Officer Sell 10b5-1 10,000 $40.00 $400.0K 22,500 −30.8% of holding
Carter Jason S Chief Legal Officer Sell 3,864 $27.82 $107.5K 49,136 −7.3% of holding
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR Sell 15,000 $29.06 $435.9K 47,839 −23.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.